APS-I/APECED: The clinical disease and therapy

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 2, 2002, Pages 295-320

  Perheentupa, Jaakko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; ALFACALCIDOL; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZATHIOPRINE; CALCIFEDIOL; CALCITONIN; CALCITRIOL; CALCIUM; CALCIUM SALT; COLECALCIFEROL; CYCLOSPORIN; DIHYDROTACHYSTEROL; DOXERCALCIFEROL; ERGOCALCIFEROL; ERGOCALCIFEROL DERIVATIVE; FLUCONAZOLE; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; MAGNESIUM CHLORIDE; MERCAPTOPURINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; PREDNISONE; RETINOL;

ADRENAL CORTEX INSUFFICIENCY; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; ECTODERMAL DYSPLASIA; FERTILITY; GALLSTONE; GASTROINTESTINAL DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPOGONADISM; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; IMMUNOPATHOLOGY; KERATOCONJUNCTIVITIS; KIDNEY DISEASE; MUCOCUTANEOUS CANDIDIASIS; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL CARE; REVIEW; SKIN DISEASE; SPLEEN DISEASE; SURVIVAL; THYROID DISEASE; ADOLESCENT; ADULT; AUTOIMMUNE POLYENDOCRINOPATHY; CHILD; CHROMOSOME 21; FEMALE; FINLAND; GENETICS; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH DISEASE; MUTATION;

ADOLESCENT; ADULT; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; CHILD; CHROMOSOMES, HUMAN, PAIR 21; FEMALE; FINLAND; HUMAN; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGE; MOUTH DISEASES; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROGNOSIS; HUMANS; MIDDLE AGED;

PNEUMOCOCCUS;

EID: 0036081840     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(01)00013-5     Document Type: Review

References (75)

1. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
2. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
3. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
4. Autoimmune polyendocrine syndrome type I
5. Autoimmune polyglandular syndrome type 1
6. Juvenile autoimmune polyendocrinopathy
7. Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyendocrine disease type I
8. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies
9. Antisperm antibodies in the polyglandular autoimmune syndrome type I: Response to cyclical steroid therapy
10. Two types of autoimmune Addison's disease with different polyglandular autoimmune syndromes
11. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I
12. Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
13. Hypocalcemia and steatorrhea - Clues to etiology
14. Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I
15. Bile salt deficiency in fat malabsorption of hypoparathyroidism
16. Autoimmune polyendocrine candidiasis syndrome with associated chronic diarrhea caused by intestinal infection and pancreas insuffiency
17. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressive therapy
18. Severe gastrointestinal dysfunction in an adolescent girl with autoimmune-polyendocrinopathy-candidiasis-ectodermaldystrophy (APECED): Additional evidence for enterochromaffin cell destruction as a cause of malabsorption
19. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats
20. Effects of serotonin on intestinal secretion and motility
21. 5-Hydroxytryptamine 4 receptor agonists initiate the peristaltic reflex in human, rat and guinea pig intestine
22. Identification of tryptophan hydroxylase as an intestinal autoantigen
23. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy successfully treated with immunosuppression
24. Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea
25. Chronic bilateral keratitis in autoimmune polyendocrino-pathy-candidiasis-ectodermal dystrophy
26. Keratitis associated with multiple endocrine deficiency, autoimmune disease, and candidiasis syndrome
27. Chronic moniliasis associated with Addison's disease
28. Microanatomy of the dental enamel in autoimmune polyendocrinopathy-candidiasisis-ectodermal dystrophy: Report of three cases
29. Oral findings in the autoimmune polyendocrinopathycandidiasis syndrome (APECED) and other forms of hypoparathyroidism
30. AIRE and HLA genotypes as determinants of APECED phenotype
31. Polyglandular autoimmune syndrome type I among Iranian Jews
32. The syndrome of hypoparathyroidism and steatorrhoea
33. The syndrome of keratoconjunctivitis, superficial moniliasis, idiopathic hypoparathyroidism and Addison's disease
34. Polyglandular autoimmune syndrome accompanied by Munchausen syndrome
35. Corneal pathology and outcome of keratoplasty in auto-immune-candidiasis-ectodermal dystrophy
36. Candida infection of the gastrointestinal tract
37. Unmasking of latent hypoparathyroidism in a child with partial DiGeorge syndrome by ethylenediaminetetraacetic acid infusion
38. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure
39. Two-hour adrenocorticotropic hormone test: Accuracy in the evaluation of the hypothalamic-pituitary-adrenocortical axis
40. Beta-cell antibodies, human leukocyte antigen II alleles, and type I diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
41. Chronic mucocutaneous candidiasis
42. Candidiasis endocrinopathy syndrome, treatment with intraconazole
43. Autoimmune polyendocrinopathy type 1: Treat with kid gloves
44. Azathioprine for long-term maintenance of remission of autoimmune hepatitis
45. Short-term cyclosporine induces a remission of autoimmune hepatitis in children
46. A randomized, cross-over trial on once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism
47. Hormones and disorders of mineral metabolism
48. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism
49. 3-treated hypoparathyroidism: 35 Patient years in 10 children
50. Autoimmune cranial diabetes insipidus: Its association with other endocrine diseases and with histiocytosis X
51. The association of diabetes insipidus with hypoparathyroidism, Addison's disease and mucocutaneous candidiasis
52. Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis
53. Familial moniliasis, defective delayed hypersensitivity and adrenocorticotropic hormone deficiency
54. Candidiasis: Studies pertaining to its association with endocrinopathies and pernicious anemia
55. Alopecia areata in a patient with candidiasis endocrinopathy syndrome: Unsuccessful treatment trial with diphenylcyclopropenone
56. Acquired splenic atrophy in a sibship with the autoimmune polyendocrinopathy-candidiasis syndrome
57. Familial chronic hypoparathyroidism associated with rheumatoid arthritis
58. Antibodies to melanocytes in vitiligo
59. Oral squamous cell carcinoma in a young person with candidosis endocrinopathy syndrome: A case report
60. Cultured thymus fragment transplant in chronic candidiasis complicated by oral carcinoma
61. Candidiasis and multiple endocrinopathy. With oral squamous cell carcinoma complications
62. Autoimmune polyglandular syndrome type 1 associated with metaphyseal osteosclerosis
63. Pure red cell aplasia and the syndrome of multiple endocrine gland insufficiency
64. Candidiasis endocrinopathy syndrome with progressive myopathy
65. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's diease
66. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and isolated Addison's disease
67. Premature ovarian failure: Autoimmunity and natural history
68. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: Comparison of immunofluorescence and immunoprecipitation assays
69. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
70. Pernicious anemia
71. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: Effect of 1,25-dihydroxyvitamin D3
72. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism
73. 3 therapy
74. Comparison between crystalline dihydrotachysterol and calciferol in patients requiring pharmacologic vitamin D therapy